FOXP3 and ovarian carcinoma: On the other hand, the full-length variant, in which the coding exon two is present, should have opposite activities, and this is confirmed by the observations using breast and ovarian cancer cells, in which the introduction of the FOXP3-FL variant decreases tumor growth, inhibits proliferation, and decreases migration and invasion [29,32].